In this article, a protocol for infection of macrophages with Cryptococcus neoformans is described. Also, a method for sterol depletion from the macrophages is explained. These protocols provide a guide to study fungal infections in vitro and examine the role of sterols in such infections.
Cryptococcosis is a life-threatening infection caused by pathogenic fungi of the genus Cryptococcus. Infection occurs upon inhalation of spores, which are able to replicate in the deep lung. Phagocytosis of Cryptococcus by macrophages is one of the ways that the disease is able to spread into the central nervous system to cause lethal meningoencephalitis. Therefore, study of the association between Cryptococcus and macrophages is important to understanding the progression of the infection. The present study describes a step-by-step protocol to study macrophage infectivity by C. neoformansin vitro. Using this protocol, the role of host sterols on host-pathogen interactions is studied. Different concentrations of methyl–cyclodextrin (MCD) were used to deplete cholesterol from murine reticulum sarcoma macrophage-like cell line J774A.1. Cholesterol depletion was confirmed and quantified using both a commercially available cholesterol quantification kit and thin layer chromatography. Cholesterol depleted cells were activated using Lipopolysacharide (LPS) and Interferon gamma (IFNγ) and infected with antibody-opsonized Cryptococcus neoformans wild-type H99 cells at an effector-to-target ratio of 1:1. Infected cells were monitored after 2 hr of incubation with C. neoformans and their phagocytic index was calculated. Cholesterol depletion resulted in a significant reduction in the phagocytic index. The presented protocols offer a convenient method to mimic the initiation of the infection process in a laboratory environment and study the role of host lipid composition on infectivity.
Phagocytosis is a process by which extracellular entities are internalized by host cells. It is a key weapon in the immune system’s arsenal to defend against pathogens, but the process may often be subverted by pathogens to allow for internalization and spreading throughout the body1. Phagocytosis is mediated by several signaling events that result in attachment and engulfment via rearrangements of the host cell’s cytoskeleton. ‘Professional’ phagocytes are able to recognize and bind to opsonins on the surface of the invading pathogen to signal for attachment and the formation of lamellipodia, which engulf the pathogen and form a phagosome2. Among the so-called ‘professional’ phagocytes are macrophages. Macrophages are highly specialized cells that carry out protective functions that include seeking out and eliminating disease causing agents, repairing damaged tissues, and mediating inflammation, most of these through the process of phagocytosis1,2.
Cryptococcus neoformans is a species of pathogenic yeast that causes a serious disease known as Cryptococcosis. Cryptococcus spores are inhaled by the host and result in a pulmonary infection that is usually asymptomatic. It is thought that exposure is extremely prevalent; a sample of 61 children from the Pediatric Infectious Diseases Clinic at the Bronx-Lebanon Hospital Center found that all those surveyed had antibodies to the cryptococcal polysaccharide glucuronoxylomannan and other studies have shown prevalence in both human immunodeficiency virus (HIV) uninfected and infected adults3,4. Alveolar macrophages are the first line of response to the pulmonary infection and in most cases successfully clear the pathogen. However, in immunocompromised individuals (e.g., HIV and AIDS patients) the yeast is able to survive within the macrophages. In these cases, the macrophages can serve as a niche for the replication of the pathogen and may facilitate its dissemination to the central nervous system (CNS) where the disease becomes fatal5–8. It is thought that macrophages may even deliver the yeast directly into the meninges, helping the yeast to cross the blood brain barrier via the “Trojan horse” model3,9–11. Thus, it is important to understand the process of phagocytosis and the factors that affect it, especially in cryptococcal infections.
Previous work in other pathogen systems point to cholesterol and lipid rafts formed by cholesterol as having an important role to play in phagocytosis12–15. Cholesterol is the most abundant lipid species in mammalian cells and comprises 25 – 50% of the mammalian cell membrane16. It has been found to play a role in modulating the biophysical properties of membranes by changing their rigidity17. Cholesterol and sphingolipids together form lipid microdomains within the membrane known as lipid rafts. Lipid rafts have been found to be involved in the formation of caveolae, as well as providing an isolated domain for certain types of signaling16–18. Due to their small size, it is difficult to study lipid rafts in vivo. One useful way to study the role of lipid rafts is to alter their constituents. Methyl-β-cyclodextrin (MβCD) is a compound that has been found to deplete cholesterol from mammalian membranes and is commonly used to study the role of lipid rafts18.
In this protocol, we present a method to deplete cholesterol from host cell membranes and quantify the effect of the depletion on the ability of the host cells to phagocytose C. neoformans in vitro. This procedure makes use of cell culture techniques on an immortalized macrophage like cell line (J774A.1) as a model for infection. Cholesterol depletion was accomplished by exposure to MβCD, which has a hydrophobic core specific to the size of sterols and is able to act as a sink for cholesterol to draw it out of the membrane19. Cholesterol depletion was measured quantitatively using a commercially available kit and qualitatively using a modified Bligh-Dyer lipid extraction followed by thin layer chromatography (TLC)20. Phagocytosis was measured by infecting the cell line with a culture of opsonized yeast mixed with a cocktail of interferon-γ and lipopolysaccharide for activating the macrophages. Cryptococcus was opsonized using a glucuronoxylomannan (GXM) antibody21–23. Staining and microscopy experiments allowed for visualization of the cells and calculation of the phagocytic index to assess the degree of phagocytosis. Taken together, this protocol describes a basic method that integrates the alteration of lipid composition with a physiological process.
1. Cholesterol Depletion of J774A.1 Cells with MβCD
2. Observation of Cholesterol Content by Thin Layer Chromatography (TLC)
3. Infection of Macrophages with C. neoformans (H99)
4. Trypan Blue Assay
Cholesterol Depletion
Analysis of the supernatant reserved in step 1.3 of the protocol by following the manufacturer’s instructions in the Amplex Red Cholesterol Assay kit yields an elevated concentration of cholesterol in MβCD treated sample as compared to the 1x PBS control. Depending on cell type and MβCD concentration used cholesterol depletion may vary. For J774 treated with 10 mM MβCD, a depletion of approximately 50% was observed. Depletion can be calculated using values obtained from the supernatant and cell lysate collected in step 1.4 (Figure 1).
Cell lysate analyzed using TLC shows a marked decrease in staining of cholesterol in cells treated with increasing concentration of MβCD (Figure 2A). Densitometry analysis of the TLC shows a similar trend to the quantitative assay (Figure 2B). The Bligh-Dyer method gives a crude extract of total lipids and it is essential to allow for adequate separation of lipids in order to identify the correct band utilizing the cholesterol standard.
Infection
After following the infection procedure, cells remain adhered and intact. Cell morphology remains unchanged between treatment groups. A control group that has not been exposed to C. neoformans serves as a checkpoint (Figure 3). It is possible to obtain suboptimal results and may manifest as lysis of cells and other abnormal morphologies. The most likely cause is contamination of the cell line or reagents used in the procedure. Micrographs of optimally infected cells clearly show C. neoformans engulfed within the mammalian cells. Differences in number of phagocytized yeast may be noted by observation between treatment groups (Figure 4). After calculating phagocytic index from 300 macrophage cells per treatment group a reduction in phagocytic index is found in cholesterol depleted cells (Figure 5). The reduction in the phagocytic index does not appear to be dependent on potential differences in macrophage activation, although they may occur. Performing the infection in the absence of macrophage activators, but after treatment with MCD results in a similar reduction of phagocytic index (data not shown).
Trypan Blue
Trypan Blue staining is used to assess the viability of cells after cholesterol depletion. No change in viability is observed between PBS treated and 10mM MCD treated cells. Viability appears to drop off slightly after treatment with 30 mM MCD, which may be expected due to the approximately 75% depletion in cholesterol (an essential lipid) observed in the densitometry analysis (Figure 6 and Figure 2B).
Figure 1. Cholesterol content of supernatant after treatment. Quantification of cholesterol in the supernatant collected from treated cells shows enrichment in MCD when compared to 1x PBS. Cholesterol depletion is 50 ± 5% calculated from total cholesterol in 1x PBS (supernatant + cell lysate). Error bars show standard deviation (n = 5).
Figure 2. TLC of cholesterol in cell lysate and densitometry. Image of developed TLC plate visualized with MnCl2 charring. A marked decrease in cholesterol is seen after MβCD treatment (A). Densitometry analysis of bands as compared to the PBS treated control (shown as 100%) confirms trend found in Cholesterol quantification assay (B). Please click here to view a larger version of this figure.
Figure 3. Uninfected control micrographs of treated J774 macrophages. Images of uninfected J774 cells taken at 200X magnification. Scale bar is 50 μm. 1x PBS (A), 10 mM MβCD (B), and 30 mM MβCD (C) treated cells show no change. Please click here to view a larger version of this figure.
Figure 4. Infection of J774 macrophages with C. neoformans. Images of infected J774 cells taken at 400X (top row A.1 – C.1) and 1,000X (bottom row A.2 – C.2) magnification are shown. Internalized C. neoformans cells appear as blue-violet spheres with a lighter ring surrounding them. Cells treated with 1x PBS (A), 10 mM MβCD (B), and 30 mM MβCD (C) show differences in C. neoformans uptake. Please click here to view a larger version of this figure.
Figure 5. Phagocytic index. Phagocytic index is shown with respect to the control group that was treated with PBS (Marked at 100 for comparison). Phagocytic index was reduced by 25% by 10 mM MβCD treatment and by almost 55% by 30 mM treatment. Error bars show standard deviation of the mean (n = 4).
Figure 6. Cell viability. Variations in cell viability by trypan blue assay show little variation when comparing all three treatment groups. There is a slight drop off in viability in the 30 mM MβCD treatment group, which can be expected from depletion of such a major component of the membrane. Error bars show standard deviation (n = 4).
In working with this protocol it is important to obtain accurate cell counts when plating mammalian cells and opsonizing C. neoformans cells. This minimizes variation between trials and ensures an accurate 1:1 target to effector ratio throughout the study. It is also critical to coordinate the timing of the cholesterol depletion and infection to prevent the opsonized yeast cells or treated macrophage cells from resting at RT in between the procedures. Long waiting periods could lead to loss of antibody opsonization or the replenishing of depleted cholesterol before infection can begin. If experiments are done with precision the data analysis allows for conclusions to be discerned about the role of cholesterol in phagocytosis.
The limitations of the technique prevent any conclusions as to the specific mechanism by which cholesterol depletion lowers the phagocytic index of macrophage like cells, and it is unclear whether the effect is directly due to cholesterol or due to a secondary mechanism. Further work along this vein investigates other constituents of lipid rafts such as sphingolipids or proteins known to function in phagocytosis such as the Fcγ receptor and the complement receptor 3 2. Modifying this technique to use either antibody opsonization or complement alone could help distinguish a role for cholesterol in one or both of these known pathways. It is also important to remember that MβCD extracts cholesterol based on its hydrophobicity and size, thus sterols of a similar size may also be depleted and will migrate at a similar rate as cholesterol on a TLC. It is also important to note that cholesterol depletion can partially affect macrophage activation, this is unlikely to be responsible for the difference observed in uptake as performing the infection in the absence of IFN- and LPS shows the same reduction in the uptake of C. neoformans (data not shown), but it is of interest when modifying this technique to study the anti-fungal activities of macrophages and the role of activation. This method also does not allow us to discern whether cholesterol depletion has any therapeutic implications in fungal infection. Further work in vivo with cholesterol-lowering drugs and epidemiological studies of patients using cholesterol-lowering drugs could further elucidate a role for cholesterol depletion in the treatment of the disease and may offer a more selective way to inhibit cholesterol accumulation.
This procedure could easily be used to study uptake of other pathogens or solid particles (i.e., glass beads) being phagocytized and allow for the study of basic biology of phagocytosis. Modifications could allow for the study of other aspects of phagocytosis by treating the macrophage cells with enzymes to selectively degrade other membrane components or various drugs and inhibitors which may be of interest. It should also be noted that flow cytometry may present a more accurate and quantitative way to characterize phagocytosis and could be used to replace the direct microscopic count24. Altogether, this is a fairly simple technique that can be used as a starting point for more in depth studies that answer questions about how lipids may play an important part in infection and immune response.
The authors have nothing to disclose.
This work was supported by NIH grants AI56168, AI71142, AI87541 and AI100631 to MDP. Maurizio Del Poeta is Burroughs Wellcome Investigator in Infectious Diseases.
Name of Reagent/ Equipment | Company | Catalog Number | Comments/Description |
Class II type A2 Biosafety Cabinet | Labconco | 3460009 | |
J774A.1 cell line | ATCC | TIB-67 | Arrives Frozen. See ATCC instructions for culturing. |
Dulbecco’s Modified Eagle Medium | Gibco | 11995-065 | Store at 4 °C and warm to 37 °C prior to use |
HI Fetal Bovine Serum Performance Plus | Gibco | 10082-147 | Keep frozen at -20 °C and thaw before adding to DMEM |
Penicillin-Streptomycin (10,000 U/mL) | Gibco | 15140-122 | Used to suplement DMEM |
Isotemp Cell culture incubator | Fisher Scientific | Model # 3530 | |
96-Well culture dish | Corning Inc. Costar | 3595 | |
10x Phosphate Buffered Saline | Fisher Scientific BioReagents | BP3994 | Dilute to 1x and filter or autoclave prior to use. |
Methyl-β-Cyclodextrin | Sigma Life Science | C4555-10G | Dissolve in 1x PBS to make solutions of 10mM and 30mM concentrations |
Orbital Shaker | Labline | ||
Amplex Red Cholesterol Assay Kit | Life Technologies Molecular Probes | A12216 | All reagents for Cholesterol Assay are contained within the kit. Follow Manufacturer instructions. |
96-Well Black Assay plate | Corning Inc. Costar | 3603 | |
FilterMax microplate reader | Molecular Devices | Model F5 | |
TLC Chamber | Sigma-Aldrich | Z126195-1EA | |
Chloroform | Sigma-Aldrich | 650498-4L | |
Methanol | Sigma-Aldrich | 34860-2L-R | |
TLC Paper | Whatman | 3030917 | Cut down to size needed for TLC tank |
Fume Hood | Any fume hood that complies with AIHA/ANSI Standards | ||
6-Well Plate | Corning Inc. Costar | 3506 | |
Trypsin-EDTA | Gibco | 25300-054 | |
Cell Scraper | Corning Inc. Costar | 3010 | |
Hemocytometer | Hausser Scientific | 1490 | |
Centrifuge | Beckman Coulter | Model Alegra x-30R | |
Votex Mixer | Fisher Scientific | 12-812 | |
Balance | Mettler Toledo | Model # MS104S Meaures down to .1 mg | |
Glass Pasteur Pipette | Fisherbrand | 13-678-20A | |
Cholesterol | Avanti Polar Lipids | 700000 | |
SpeedVac Concentrator | Thermo Scientific | Model # SPD2010 | |
Petroleum Ether | Fisher Scientific | E139-1 | |
Diethyl Ether | Sigma-Aldrich | 309966 | |
Acetic Acid | Sigma-Aldrich | 320099 | |
TLC Silica Gel 60 with concentrating zone | Analytical Chromatograhy Millipore | 1.11845.0001 | |
Iodine Chips | Sigma-Aldrich | 376558-50G | |
Sulfuric Acid | Sigma-Aldrich | 320501 | |
Manganese Chloride | Sigma-Aldrich | 244589 | |
UVP EC3 Imaging System | Ultra-Violet Products Ltd. | Use the Vision Works LS software for densitometry analysis | |
Glass Bottom Confocal Dish | MatTek | P35G-1.5-10C | www.glassbottomdishes.com |
Cryptococcus neoformans (H99) | Obtained from Duke University Medical Center | ||
YNB | BD | 239210 | See manufacturer for preparation instructions. Use a Glucose concentration of 20 g/L. |
Lipopolysaccharide | Sigma | L4391-1MG | Dissolve in 1x PBS to make 1mg/mL stock. Store at -20 °C. |
Interferon gamma | Sigma | I4777 | Dissolve in 1x PBS to make .1 mg/mL stock solution |
Glucuronoxylomannan antibody (anti-GXM) | Gift from Arturo Casadevall's Lab concentration is 1.98 mg/mL | ||
Giemsa | MP Biomedicals | 194591 | Dissolve .8 g of Giemsa in 25 mL of Glycerol and heat to 60 °C for 1 hour. Add 25 mL of methanol to the solution and allow to age at room temperature for at least 1 month. |
Microscope | Zeiss | Observer.D1 microscope with AxioCam MRm for taking images |